Rhythm Pharmaceuticals Inc (RYTM)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | David P. Meeker |
| Employees: | 140 |
| Web site: | rhythmtx.com |
|
222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
857-264-4280
| |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Rhythm Pharmaceuticals, Inc. focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency.
Please log in first to see chart